Singapore, July 22 -- As Malaysia confronts a significant surge in Tuberculosis (TB) cases, with over 3,100 confirmed infections recorded in the first two months of 2026 alone, Medical Innovation Ventures Sdn. Bhd. (Mediven(R)) has announced that the Pluslife MiniDock MTB Test is now an MDA-registered medical device under the Medical Device Authority (MDA).

This landmark approval introduces a World Health Organization (WHO) recommended, "first-in-class" molecular diagnostic tool to the Malaysian market.

The system is specifically designed to decentralise TB detection and accelerate treatment in community settings, prisons, and rural hotspots, directly addressing the limitations of traditional laboratory infrastructure.

The approval of ...